Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
British Journal of Cancer|April 8, 2025
Infectious agents and progression from Barrett's oesophagus to oesophageal adenocarcinoma: a nested case-control studyTalita H A de Oliveira, Lesley A Anderson, Stephanie G Craig, et al.British Journal of Cancer|June 9, 2017
Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapiesMuhammad A Alvi, Maurice B Loughrey, Philip Dunne, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2019
Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern IrelandStephanie G Craig, Lesley A Anderson, Michael Moran, et al.NPJ Breast Cancer|June 26, 2021
The clinical and molecular significance associated with STING signaling in breast cancerEileen E Parkes, Matthew P Humphries, Elaine Gilmore, et al.British Journal of Cancer|May 20, 2017
Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort studyRonan T Gray, Maurice B Loughrey, Peter Bankhead, et al.Journal of Oncology|January 18, 2019
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerMatthew P Humphries, Sean Hynes, Victoria Bingham, et al.British Journal of Cancer|March 21, 2019
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approachStephanie G Craig, Lesley A Anderson, Andrew G Schache, et al.Oncotarget|August 29, 2015
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utilityMuhammad A Alvi, Darragh G McArt, Paul Kelly, et al.Clinical and Translational Gastroenterology|April 28, 2017
Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort StudyRonan T Gray, Marie M Cantwell, Helen G Coleman, et al.Oncotarget|March 24, 2018
Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancerPhilip D Dunne, Helen G Coleman, Peter Bankhead, et al.Pageof 5